BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2189041)

  • 1. Concordant dyslipidemia, hypertension and early coronary disease in Utah families.
    Williams RR; Hunt SC; Wu LL; Hopkins PN; Hasstedt SJ; Schumacher MC; Stults BM; Kuida H
    Klin Wochenschr; 1990; 68 Suppl 20():53-9. PubMed ID: 2189041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah.
    Williams RR; Hopkins PN; Hunt SC; Wu LL; Hasstedt SJ; Lalouel JM; Ash KO; Stults BM; Kuida H
    Arch Intern Med; 1990 Mar; 150(3):582-8. PubMed ID: 2310276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for gene-environmental interactions in Utah families with hypertension, dyslipidaemia and early coronary heart disease.
    Williams RR; Hunt SC; Hopkins PN; Wu LL; Schumacher MC; Stults BM; Ball L; Ware J; Hasstedt SJ; Lalouel JM
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():1-6. PubMed ID: 1446402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of coronary risk factors among Indian physicians.
    Gupta A; Gupta R; Lal B; Singh AK; Kothari K
    J Assoc Physicians India; 2001 Dec; 49():1148-52. PubMed ID: 11996433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
    ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.
    Williams RR; Hunt SC; Hopkins PN; Stults BM; Wu LL; Hasstedt SJ; Barlow GK; Stephenson SH; Lalouel JM; Kuida H
    JAMA; 1988 Jun; 259(24):3579-86. PubMed ID: 3373705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of insulin resistance in familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-degree kinship with young coronary artery disease patients markedly increases lipid-level disorders in asymptomatic hypertensives.
    Giannini SD; Diament J; Forti N; Issa JS; Dal Bó C; Fukushima J; Barretto AC
    J Cardiovasc Risk; 1998 Jun; 5(3):141-5. PubMed ID: 10201549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
    Williams RR; Hunt SC; Hopkins PN; Wu LL; Hasstedt SJ; Berry TD; Barlow GK; Stults BM; Schumacher MC; Ludwig EH
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):319S-327S. PubMed ID: 8297539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.